Dra. Sandra Massry, Homeopatía y Lactancia IBCLC

28/04/2026

ABM’s Board of Directors provides visionary leadership and strategic guidance to advance the organization's mission. Comprised of dedicated physician volunteers from around the world, the Board oversees governance, ensures financial stewardship, and helps shape the direction of breastfeeding medicine globally. Their commitment, insight, and collaboration drive ABM forward, strengthening our community and our impact.

27/04/2026

Interesting... "Third-trimester pineapple consumption was associated with improved cervical ripening, shorter labor duration, and higher rates of spontaneous vaginal delivery without adverse neonatal outcomes. These findings support further investigation of dietary influences on labor outcomes."
https://journals.lww.com/md-journal/fulltext/2026/04170/the_impact_of_pineapple_consumption_on_cervical.18.aspx

23/04/2026

The Governance Committee ensures ABM’s leadership structure remains strong, effective, and mission-driven. This dedicated team reviews organizational policies, maintains compliance with best governance practices, and strengthens the framework that supports ABM’s operations. Their work is essential to the organization’s foundation and long-term sustainability.

18/04/2026

08/04/2026

Me convertí en IBCLC hace 20 años, lo hice porque después de haber estudiado medicina y he hecho una maestría en nutrición Clinica aún no sabía nada de lactancia y me di cuenta de que la mayoría de mis colegas tampoco. Ha sido un camino lleno de satisfacciones, retos, estudio y estoy muy orgullosa de ser socia, fundadora y asociada de esta maravillosa organización.

Desde hace varios años, también me dedico a la medicina en lactancia y tengo perfectamente claro que son dos formas distintas de ayudar a las mamás y a las familias a lograr sus metas de alimentación. Las dos son necesarias y tienen su campo de acción.

23/03/2026

Plantar fasciitis (PF) is a chronic degenerative condition causing marked thickening and fibrosis of the plantar fascia, and collagen necrosis, chondroid metaplasia and calcification.

A recent double-blind, randomized, placebo-controlled trial examined the efficacy of individualized homeopathic medicines (IHMs) compared with placebo in the treatment of PF.

The results:
The target sample size was 128; however, only 75 could be enrolled (IHMs: 37; Placebo: 38). Attrition rate was 9.3% (IHMs: 4, Placebo: 3). Differences between groups in total FFI% score favored IHMs against placebo at all the time points, with large effect sizes: month 1 (mean difference, -10.0; 95% confidence interval [CI], -15.7 to -4.2; p = 0.001; d = 0.8); month 2 (mean difference, -14.3; 95% CI, -20.4 to -8.2; p

17/03/2026

A number of German statutory health insurance companies are offering integrated care contracts for homeopathy (ICCHs) that cover the reimbursement of homeopathic treatment.

So does homeopathic treatment work? Researchers conducted a comparative, prospective, observational study in which participants in the ICCH (HOM group) were compared with matched (on diagnosis, s*x and age) insured individuals (CON group) who received usual care alone.

The findings?
"Data from 2,524 participants (1,543 HOM group) were analyzed. The primary effectiveness outcomes after six months were statistically significant in favor of the HOM group for migraine or headache (Δ = difference between groups, days with headache: − 0.9, p = 0.042), asthma (Δ-AQLQ(S): + 0.4, p = 0.014), atopic dermatitis (Δ-DLQI: − 5.6, p ≤ 0.001) and depression (Δ-BDI-II: − 5.6, p ≤ 0.001).

Source: Kass, B., et al., Effectiveness and cost-effectiveness of treatment with additional enrollment to a homeopathic integrated care contract in Germany. BMC Health Services Research volume 20, Article number: 872 (2020)

10/03/2026

In a Taiwanese cohort study, prenatal prescriptions were associated with offspring and risk in the full sample but not in sibling-matched analyses, highlighting unresolved bias.

https://ja.ma/4cUxVGH

03/03/2026

Interesante

Robert F. Kennedy Jr. has publicly claimed that the CDC concealed an internal study suggesting a 1,135% increase in autism risk linked to the hepatitis B vaccine. These statements have sparked widespread attention and controversy, raising questions about vaccine safety, public trust, and the interpretation of epidemiological data.

The CDC maintains that extensive research, including large-scale population studies, shows no credible evidence linking routine childhood vaccines, including hepatitis B, to autism. Vaccines undergo rigorous clinical trials and continuous safety monitoring to identify potential adverse effects. Independent peer-reviewed studies consistently find that vaccination is safe and effective, providing critical protection against preventable diseases.

Public health experts emphasize the importance of critically evaluating claims and relying on verified scientific evidence. Misinterpretation or dissemination of unverified data can fuel vaccine hesitancy, potentially increasing the risk of outbreaks for highly contagious diseases such as hepatitis B, measles, and whooping cough.

While vaccine safety continues to be closely monitored, mainstream scientific consensus holds that vaccines remain a cornerstone of public health, preventing severe illness, hospitalization, and death. Authorities encourage transparent communication, evidence-based review, and ongoing research to maintain public confidence in immunization programs.

This controversy highlights the ongoing need for careful interpretation of studies and clear guidance from trusted public health institutions to ensure informed decisions regarding vaccination.

26/02/2026

A double-blind, randomised, placebo-controlled trial involving 140 children with nocturnal enuresis found that individualised homeopathic treatment significantly reduced the frequency of bedwetting over three months compared with placebo, while both groups received standard supportive care.

The findings suggest that individualised homeopathic medicines offer a beneficial and safe complementary option for managing childhood bedwetting, though further independent studies are needed to confirm the results.

Read the study here: https://pubmed.ncbi.nlm.nih.gov/39580875/

18/02/2026

Médicos, personal de salud, no se le pueden perder!!

The 2026 ABM Annual Meeting is on the calendar. 📅

We’re looking forward to bringing our community together again for education, connection, and collaboration in breastfeeding medicine this Fall in Toronto. Save the date and stay tuned, the Call for Abstracts opens by March 1.

08/02/2026

A 2025 study published in AJOG adds powerful, up-to-date data showing associations between doula care and improved maternal and newborn outcomes.

Key Maternal Outcomes:

More vaginal births after cesarean (VBAC): For every 100 patients who received doula care, there were 15 to 34 additional VBACs compared with those without doula care.

Higher postpartum follow-up attendance: 5 to 6 more per 100 received postpartum office visits.

Key Neonatal / Infant Outcomes

Increased exclusive breastfeeding rates: Babies whose families had doula support were more likely to breastfeed exclusively.

Fewer preterm births (and early preterm births): Doula-supported births showed a reduction in preterm birth rates.

In short, the study links doula care with improvements in birth outcomes — across birth mode (more VBACs), infant health (less prematurity), and early infant care (breastfeeding, postpartum follow-up).

Read more: https://internationaldoulainstitute.com/2025/11/evidence-for-doulas-new-ajog-study-finds-doulas-improve-outcomes/